These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
382 related items for PubMed ID: 24708011
1. Tranexamic acid for trauma: filling the 'GAP' in evidence. Mitra B, Mazur S, Cameron PA, Bernard S, Burns B, Smith A, Rashford S, Fitzgerald M, Smith K, Gruen RL, PATCH-Trauma Study Investigators. Emerg Med Australas; 2014 Apr; 26(2):194-7. PubMed ID: 24708011 [Abstract] [Full Text] [Related]
3. Effect of tranexamic acid administration on acute traumatic coagulopathy in rats with polytrauma and hemorrhage. Wu X, Benov A, Darlington DN, Keesee JD, Liu B, Cap AP. PLoS One; 2019 Jan; 14(10):e0223406. PubMed ID: 31581265 [Abstract] [Full Text] [Related]
4. Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) Study. Morrison JJ, Dubose JJ, Rasmussen TE, Midwinter MJ. Arch Surg; 2012 Feb; 147(2):113-9. PubMed ID: 22006852 [Abstract] [Full Text] [Related]
7. Tranexamic acid as part of remote damage-control resuscitation in the prehospital setting: A critical appraisal of the medical literature and available alternatives. Ausset S, Glassberg E, Nadler R, Sunde G, Cap AP, Hoffmann C, Plang S, Sailliol A. J Trauma Acute Care Surg; 2015 Jun; 78(6 Suppl 1):S70-5. PubMed ID: 26002268 [Abstract] [Full Text] [Related]
10. Mechanism of action of tranexamic acid in bleeding trauma patients: an exploratory analysis of data from the CRASH-2 trial. Roberts I, Prieto-Merino D, Manno D. Crit Care; 2014 Dec 13; 18(6):685. PubMed ID: 25498484 [Abstract] [Full Text] [Related]
13. Understanding the neuroprotective effect of tranexamic acid: an exploratory analysis of the CRASH-3 randomised trial. Brenner A, Belli A, Chaudhri R, Coats T, Frimley L, Jamaluddin SF, Jooma R, Mansukhani R, Sandercock P, Shakur-Still H, Shokunbi T, Roberts I, CRASH-3 trial collaborators. Crit Care; 2020 Nov 11; 24(1):560. PubMed ID: 33172504 [Abstract] [Full Text] [Related]
14. Geographical Variance in the Use of Tranexamic Acid for Major Trauma Patients. Walsh K, O'Keeffe F, Mitra B. Medicina (Kaunas); 2019 Sep 02; 55(9):. PubMed ID: 31480783 [Abstract] [Full Text] [Related]
15. Use of tranexamic acid in major trauma: a sex-disaggregated analysis of the Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage (CRASH-2 and CRASH-3) trials and UK trauma registry (Trauma and Audit Research Network) data. Nutbeam T, Roberts I, Weekes L, Shakur-Still H, Brenner A, Ageron FX. Br J Anaesth; 2022 Aug 02; 129(2):191-199. PubMed ID: 35597623 [Abstract] [Full Text] [Related]
17. Severely injured trauma patients with admission hyperfibrinolysis: Is there a role of tranexamic acid? Findings from the PROPPR trial. Khan M, Jehan F, Bulger EM, OʼKeeffe T, Holcomb JB, Wade CE, Schreiber MA, Joseph B, PROPPR Study Group. J Trauma Acute Care Surg; 2018 Nov 02; 85(5):851-857. PubMed ID: 29985230 [Abstract] [Full Text] [Related]